Compare ARK Genomic Revolution ETF (ARKG) vs Vistra Corp (VST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Vistra Corp — how do they compare? ARK Genomic Revolution ETF trades at $44.36, while Vistra Corp trades at $145.99 (market cap $48.64B). The key difference: Vistra Corp pays a 0.63% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Vistra Corp nearer its low. Which is the better fit depends on your goals.
| ARKG | VST | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $217.92 |
52-Week Low | $24.02 | $134.71 |
Market Cap | — | $48.64B |
Enterprise Value | — | $70.58B |
Dividend Yield | — | 0.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Vistra Corp
Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →
